CCCC
#3037
C4 Therapeutics, Inc. - Common Stock
3.8 9 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.77%
Monthly Change
-2.26%
6 month change
+66.24%
Year Change
+63.45%
Previous Close
3.9 2
Open
3.8 2
Low
3.7 8
High
3.9 1
Volume
503
Financials
- Market Capitalization 430.11 M
- Employee 104
- Founded 2015
- CEO N/A
- Website www.c4therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00BV2Y9B7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.5
Price to sales ratio
4.4
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3014 |  EVMN Evommune, Inc. Common Stock | 12.22 USD | +0.91% | -9.95% | -38.96% | -29.45% | 440.14 M USD | ||
| 3015 |  SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.55 USD | +5.59% | -3.21% | +15.09% | -19.68% | 466.23 M USD | ||
| 3048 |  ASMB Assembly Biosciences, Inc. - Common Stock | 26.86 USD | -0.37% | -6.28% | +13.48% | -8.72% | 426.88 M USD | ||
| 3052 |  TENX Tenax Therapeutics, Inc. - Common Stock | 15.96 USD | -0.13% | -0.56% | +37.00% | +111.39% | 423.34 M USD |
Frequently asked questions about C4 Therapeutics, Inc. - Common Stock
What is the C4 Therapeutics, Inc. - Common Stock stock price today?
The current price of C4 Therapeutics, Inc. - Common Stock (CCCC) is 3.89. Over the past 24 hours, the stock has changed by -0.77%. Follow the CCCC chart for real-time price dynamics.
What is the stock ticker of C4 Therapeutics, Inc. - Common Stock?
C4 Therapeutics, Inc. - Common Stock trades under the ticker CCCC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is C4 Therapeutics, Inc. - Common Stock stock going up?
CCCC has changed by -10.37% over the last week, -2.26% over the last month, and +63.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was C4 Therapeutics, Inc. - Common Stock net income for the last quarter?
C4 Therapeutics, Inc. - Common Stock reported net income of -25.13 M for the last quarter. The previous quarter showed -20.49 M, which means net income changed by -22.66%.
How many employees does C4 Therapeutics, Inc. - Common Stock have?
As of the latest available data, C4 Therapeutics, Inc. - Common Stock has 104 employees. Workforce size can provide additional context about the company's scale and operations.
What is C4 Therapeutics, Inc. - Common Stock EBITDA?
C4 Therapeutics, Inc. - Common Stock EBITDA is -27.38 M, and its EBITDA margin is -445.07%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy C4 Therapeutics, Inc. - Common Stock stock?
You can buy C4 Therapeutics, Inc. - Common Stock (CCCC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in C4 Therapeutics, Inc. - Common Stock stock?
Investing in C4 Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CCCC chart and related analysis on metatrader.com as part of your research.